Gut
DPP-4 inhibitor alleviates gut-brain axis pathology in Parkinson's disease.
Seong Ho Jeong, Yeon Ju Kim, Jin Young Shin, Kyu Won Oh, Jung Wook Lee, Phil Hyu Lee
Published: 202510.1136/gutjnl-2025-334988
Abstract
BACKGROUND: Dipeptidyl peptidase-4 inhibitors (DPP-4is) have been reported to exhibit therapeutic effects in Parkinson's disease (PD), increasing their potential for drug repurposing. One aspect of PD pathogenesis is thought to be associated with the…
Preview only. Read the full abstract at the source